Industry Research Reports

Home > Reports > Medical Care > Women’s Health Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Women’s Health Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 105 Pages

Report ld: 2337013

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Women's health in dermatology covers a vast array of topics that range from issues surrounding management of skin disease during pregnancy and lactation, available hormonal therapies for conditions such as acne and alopecia, hormonally driven conditions that are linked to dermatologic skin diseases such as polycystic, etc.

The global market for Women’s Health Therapeutics was estimated to be worth US$ 103880 million in 2023 and is forecast to a readjusted size of US$ 150590 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Women’s Health Therapeutics Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Women’s Health Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Women’s Health Therapeutics by region & country, by Type, and by Application.

The Women’s Health Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Women’s Health Therapeutics.

Market Segmentation

Report Metric
Details
Report Title
Women’s Health Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 150590 million
CAGR(2024-2030)
5%
Market Size Available for Years
2019-2030
Global Women’s Health Therapeutics Companies Covered
Bayer AG, Pfizer, Inc., Teva Pharmaceutical, F. Hoffmann-La Roche Ltd., Merck and Co., Inc., Bristol-Myers Squibb Company, AstraZeneca, Novartis AG, Eli Lilly and Company, GlaxoSmithKline plc, Mylan N.V., Sanofi, Sun Pharmaceutical Industries Ltd., CooperSurgical, Inc.
Global Women’s Health Therapeutics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Women’s Health Therapeutics Market, Segment by Type
Infection

Pregnancy

Oncology
Global Women’s Health Therapeutics Market, Segment by Application
Below 20 Years Old

20~50 Years Old

Above 50 Years Old
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Women’s Health Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Women’s Health Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Women’s Health Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

 1 Market Overview
    1.1 Women’s Health Therapeutics Product Introduction
    1.2 Global Women’s Health Therapeutics Market Size Forecast
    1.3 Women’s Health Therapeutics Market Trends & Drivers
        1.3.1 Women’s Health Therapeutics Industry Trends
        1.3.2 Women’s Health Therapeutics Market Drivers & Opportunity
        1.3.3 Women’s Health Therapeutics Market Challenges
        1.3.4 Women’s Health Therapeutics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Women’s Health Therapeutics Players Revenue Ranking (2023)
    2.2 Global Women’s Health Therapeutics Revenue by Company (2019-2024)
    2.3 Key Companies Women’s Health Therapeutics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Women’s Health Therapeutics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Women’s Health Therapeutics
    2.6 Women’s Health Therapeutics Market Competitive Analysis
        2.6.1 Women’s Health Therapeutics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Women’s Health Therapeutics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Infection
        3.1.2 Pregnancy
        3.1.3 Oncology
    3.2 Global Women’s Health Therapeutics Sales Value by Type
        3.2.1 Global Women’s Health Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Women’s Health Therapeutics Sales Value, by Type (2019-2030)
        3.2.3 Global Women’s Health Therapeutics Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Below 20 Years Old
        4.1.2 20~50 Years Old
        4.1.3 Above 50 Years Old
    4.2 Global Women’s Health Therapeutics Sales Value by Application
        4.2.1 Global Women’s Health Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Women’s Health Therapeutics Sales Value, by Application (2019-2030)
        4.2.3 Global Women’s Health Therapeutics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Women’s Health Therapeutics Sales Value by Region
        5.1.1 Global Women’s Health Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Women’s Health Therapeutics Sales Value by Region (2019-2024)
        5.1.3 Global Women’s Health Therapeutics Sales Value by Region (2025-2030)
        5.1.4 Global Women’s Health Therapeutics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Women’s Health Therapeutics Sales Value, 2019-2030
        5.2.2 North America Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Women’s Health Therapeutics Sales Value, 2019-2030
        5.3.2 Europe Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Women’s Health Therapeutics Sales Value, 2019-2030
        5.4.2 Asia Pacific Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Women’s Health Therapeutics Sales Value, 2019-2030
        5.5.2 South America Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Women’s Health Therapeutics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Women’s Health Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Women’s Health Therapeutics Sales Value
    6.3 United States
        6.3.1 United States Women’s Health Therapeutics Sales Value, 2019-2030
        6.3.2 United States Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Women’s Health Therapeutics Sales Value, 2019-2030
        6.4.2 Europe Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Women’s Health Therapeutics Sales Value, 2019-2030
        6.5.2 China Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Women’s Health Therapeutics Sales Value, 2019-2030
        6.6.2 Japan Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Women’s Health Therapeutics Sales Value, 2019-2030
        6.7.2 South Korea Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Women’s Health Therapeutics Sales Value, 2019-2030
        6.8.2 Southeast Asia Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Women’s Health Therapeutics Sales Value, 2019-2030
        6.9.2 India Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Women’s Health Therapeutics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bayer AG
        7.1.1 Bayer AG Profile
        7.1.2 Bayer AG Main Business
        7.1.3 Bayer AG Women’s Health Therapeutics Products, Services and Solutions
        7.1.4 Bayer AG Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.1.5 Bayer AG Recent Developments
    7.2 Pfizer, Inc.
        7.2.1 Pfizer, Inc. Profile
        7.2.2 Pfizer, Inc. Main Business
        7.2.3 Pfizer, Inc. Women’s Health Therapeutics Products, Services and Solutions
        7.2.4 Pfizer, Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.2.5 Pfizer, Inc. Recent Developments
    7.3 Teva Pharmaceutical
        7.3.1 Teva Pharmaceutical Profile
        7.3.2 Teva Pharmaceutical Main Business
        7.3.3 Teva Pharmaceutical Women’s Health Therapeutics Products, Services and Solutions
        7.3.4 Teva Pharmaceutical Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
    7.4 F. Hoffmann-La Roche Ltd.
        7.4.1 F. Hoffmann-La Roche Ltd. Profile
        7.4.2 F. Hoffmann-La Roche Ltd. Main Business
        7.4.3 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Products, Services and Solutions
        7.4.4 F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
    7.5 Merck and Co., Inc.
        7.5.1 Merck and Co., Inc. Profile
        7.5.2 Merck and Co., Inc. Main Business
        7.5.3 Merck and Co., Inc. Women’s Health Therapeutics Products, Services and Solutions
        7.5.4 Merck and Co., Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.5.5 Merck and Co., Inc. Recent Developments
    7.6 Bristol-Myers Squibb Company
        7.6.1 Bristol-Myers Squibb Company Profile
        7.6.2 Bristol-Myers Squibb Company Main Business
        7.6.3 Bristol-Myers Squibb Company Women’s Health Therapeutics Products, Services and Solutions
        7.6.4 Bristol-Myers Squibb Company Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.6.5 Bristol-Myers Squibb Company Recent Developments
    7.7 AstraZeneca
        7.7.1 AstraZeneca Profile
        7.7.2 AstraZeneca Main Business
        7.7.3 AstraZeneca Women’s Health Therapeutics Products, Services and Solutions
        7.7.4 AstraZeneca Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.7.5 AstraZeneca Recent Developments
    7.8 Novartis AG
        7.8.1 Novartis AG Profile
        7.8.2 Novartis AG Main Business
        7.8.3 Novartis AG Women’s Health Therapeutics Products, Services and Solutions
        7.8.4 Novartis AG Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.8.5 Novartis AG Recent Developments
    7.9 Eli Lilly and Company
        7.9.1 Eli Lilly and Company Profile
        7.9.2 Eli Lilly and Company Main Business
        7.9.3 Eli Lilly and Company Women’s Health Therapeutics Products, Services and Solutions
        7.9.4 Eli Lilly and Company Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.9.5 Eli Lilly and Company Recent Developments
    7.10 GlaxoSmithKline plc
        7.10.1 GlaxoSmithKline plc Profile
        7.10.2 GlaxoSmithKline plc Main Business
        7.10.3 GlaxoSmithKline plc Women’s Health Therapeutics Products, Services and Solutions
        7.10.4 GlaxoSmithKline plc Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.10.5 GlaxoSmithKline plc Recent Developments
    7.11 Mylan N.V.
        7.11.1 Mylan N.V. Profile
        7.11.2 Mylan N.V. Main Business
        7.11.3 Mylan N.V. Women’s Health Therapeutics Products, Services and Solutions
        7.11.4 Mylan N.V. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.11.5 Mylan N.V. Recent Developments
    7.12 Sanofi
        7.12.1 Sanofi Profile
        7.12.2 Sanofi Main Business
        7.12.3 Sanofi Women’s Health Therapeutics Products, Services and Solutions
        7.12.4 Sanofi Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.12.5 Sanofi Recent Developments
    7.13 Sun Pharmaceutical Industries Ltd.
        7.13.1 Sun Pharmaceutical Industries Ltd. Profile
        7.13.2 Sun Pharmaceutical Industries Ltd. Main Business
        7.13.3 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Products, Services and Solutions
        7.13.4 Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
    7.14 CooperSurgical, Inc.
        7.14.1 CooperSurgical, Inc. Profile
        7.14.2 CooperSurgical, Inc. Main Business
        7.14.3 CooperSurgical, Inc. Women’s Health Therapeutics Products, Services and Solutions
        7.14.4 CooperSurgical, Inc. Women’s Health Therapeutics Revenue (US$ Million) & (2019-2024)
        7.14.5 CooperSurgical, Inc. Recent Developments

 8 Industry Chain Analysis
    8.1 Women’s Health Therapeutics Industrial Chain
    8.2 Women’s Health Therapeutics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Women’s Health Therapeutics Sales Model
        8.5.2 Sales Channel
        8.5.3 Women’s Health Therapeutics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Women’s Health Therapeutics Market Trends
    Table 2. Women’s Health Therapeutics Market Drivers & Opportunity
    Table 3. Women’s Health Therapeutics Market Challenges
    Table 4. Women’s Health Therapeutics Market Restraints
    Table 5. Global Women’s Health Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Women’s Health Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Women’s Health Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Women’s Health Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Women’s Health Therapeutics
    Table 10. Global Women’s Health Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Women’s Health Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Women’s Health Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Women’s Health Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Women’s Health Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Women’s Health Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Women’s Health Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Women’s Health Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Women’s Health Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Women’s Health Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Women’s Health Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Women’s Health Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Women’s Health Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Women’s Health Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Women’s Health Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Women’s Health Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Women’s Health Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Women’s Health Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Women’s Health Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Women’s Health Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bayer AG Basic Information List
    Table 32. Bayer AG Description and Business Overview
    Table 33. Bayer AG Women’s Health Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Women’s Health Therapeutics Business of Bayer AG (2019-2024)
    Table 35. Bayer AG Recent Developments
    Table 36. Pfizer, Inc. Basic Information List
    Table 37. Pfizer, Inc. Description and Business Overview
    Table 38. Pfizer, Inc. Women’s Health Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Women’s Health Therapeutics Business of Pfizer, Inc. (2019-2024)
    Table 40. Pfizer, Inc. Recent Developments
    Table 41. Teva Pharmaceutical Basic Information List
    Table 42. Teva Pharmaceutical Description and Business Overview
    Table 43. Teva Pharmaceutical Women’s Health Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Women’s Health Therapeutics Business of Teva Pharmaceutical (2019-2024)
    Table 45. Teva Pharmaceutical Recent Developments
    Table 46. F. Hoffmann-La Roche Ltd. Basic Information List
    Table 47. F. Hoffmann-La Roche Ltd. Description and Business Overview
    Table 48. F. Hoffmann-La Roche Ltd. Women’s Health Therapeutics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Women’s Health Therapeutics Business of F. Hoffmann-La Roche Ltd. (2019-2024)
    Table 50. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 51. Merck and Co., Inc. Basic Information List
    Table 52. Merck and Co., Inc. Description and Business Overview
    Table 53. Merck and Co., Inc. Women’s Health Therapeutics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Women’s Health Therapeutics Business of Merck and Co., Inc. (2019-2024)
    Table 55. Merck and Co., Inc. Recent Developments
    Table 56. Bristol-Myers Squibb Company Basic Information List
    Table 57. Bristol-Myers Squibb Company Description and Business Overview
    Table 58. Bristol-Myers Squibb Company Women’s Health Therapeutics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Women’s Health Therapeutics Business of Bristol-Myers Squibb Company (2019-2024)
    Table 60. Bristol-Myers Squibb Company Recent Developments
    Table 61. AstraZeneca Basic Information List
    Table 62. AstraZeneca Description and Business Overview
    Table 63. AstraZeneca Women’s Health Therapeutics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Women’s Health Therapeutics Business of AstraZeneca (2019-2024)
    Table 65. AstraZeneca Recent Developments
    Table 66. Novartis AG Basic Information List
    Table 67. Novartis AG Description and Business Overview
    Table 68. Novartis AG Women’s Health Therapeutics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Women’s Health Therapeutics Business of Novartis AG (2019-2024)
    Table 70. Novartis AG Recent Developments
    Table 71. Eli Lilly and Company Basic Information List
    Table 72. Eli Lilly and Company Description and Business Overview
    Table 73. Eli Lilly and Company Women’s Health Therapeutics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Women’s Health Therapeutics Business of Eli Lilly and Company (2019-2024)
    Table 75. Eli Lilly and Company Recent Developments
    Table 76. GlaxoSmithKline plc Basic Information List
    Table 77. GlaxoSmithKline plc Description and Business Overview
    Table 78. GlaxoSmithKline plc Women’s Health Therapeutics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Women’s Health Therapeutics Business of GlaxoSmithKline plc (2019-2024)
    Table 80. GlaxoSmithKline plc Recent Developments
    Table 81. Mylan N.V. Basic Information List
    Table 82. Mylan N.V. Description and Business Overview
    Table 83. Mylan N.V. Women’s Health Therapeutics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Women’s Health Therapeutics Business of Mylan N.V. (2019-2024)
    Table 85. Mylan N.V. Recent Developments
    Table 86. Sanofi Basic Information List
    Table 87. Sanofi Description and Business Overview
    Table 88. Sanofi Women’s Health Therapeutics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Women’s Health Therapeutics Business of Sanofi (2019-2024)
    Table 90. Sanofi Recent Developments
    Table 91. Sun Pharmaceutical Industries Ltd. Basic Information List
    Table 92. Sun Pharmaceutical Industries Ltd. Description and Business Overview
    Table 93. Sun Pharmaceutical Industries Ltd. Women’s Health Therapeutics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Women’s Health Therapeutics Business of Sun Pharmaceutical Industries Ltd. (2019-2024)
    Table 95. Sun Pharmaceutical Industries Ltd. Recent Developments
    Table 96. CooperSurgical, Inc. Basic Information List
    Table 97. CooperSurgical, Inc. Description and Business Overview
    Table 98. CooperSurgical, Inc. Women’s Health Therapeutics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Women’s Health Therapeutics Business of CooperSurgical, Inc. (2019-2024)
    Table 100. CooperSurgical, Inc. Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Women’s Health Therapeutics Downstream Customers
    Table 104. Women’s Health Therapeutics Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Women’s Health Therapeutics Product Picture
    Figure 2. Global Women’s Health Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Women’s Health Therapeutics Report Years Considered
    Figure 5. Global Women’s Health Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Women’s Health Therapeutics Revenue in 2023
    Figure 7. Women’s Health Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Infection Picture
    Figure 9. Pregnancy Picture
    Figure 10. Oncology Picture
    Figure 11. Global Women’s Health Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Women’s Health Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Below 20 Years Old
    Figure 14. Product Picture of 20~50 Years Old
    Figure 15. Product Picture of Above 50 Years Old
    Figure 16. Global Women’s Health Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Women’s Health Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Women’s Health Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Women’s Health Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Women’s Health Therapeutics Sales Value (%), (2019-2030)
    Figure 29. United States Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Women’s Health Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Women’s Health Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Women’s Health Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Women’s Health Therapeutics Industrial Chain
    Figure 51. Women’s Health Therapeutics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Women's health in dermatology covers a vast array of topics that range from issues surrounding management of skin disease during pregnancy and lactation, available hormonal therapies for conditions such as acne and alopecia, hormonally driven conditions that are linked to dermatologic skin diseases such as polycystic, etc.

The global market for Women’s Health Therapeutics was estimated to be worth US$ 103880 million in 2023 and is forecast to a readjusted size of US$ 150590 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030

Market Segmentation

Industry: Medical Care

Published: 2024-01-24

Pages: 105 Pages

Report ld: 2337013

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3950.00

Multi Users License

USD 5925.00